Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol versus oxytocin infusion for bleeding reduction at cesarean section
IRCT201109104025N4Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Mar 2011; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT201109104025N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201109104025N4.